Literature DB >> 19475697

Meta-analysis on drugs in people with eating disorders.

Ana Calero-Elvira1, Isabel Krug, Kimberley Davis, Carolina López, Fernando Fernández-Aranda, Janet Treasure.   

Abstract

OBJECTIVE: The aim of this study was to examine whether drug use (DU) is higher in people with eating disorders (EDs) compared to a healthy control group and to perform a meta-analysis on the literature related to DU in people with EDs.
METHOD: We searched electronic databases (Medline, PsycINFO, Web of Science and CINAHL) and reviewed studies published from 1994 to August, 2007, in English, German or Spanish. A total of 16 papers fulfilled the inclusion criteria and were included.
RESULTS: The general meta-analysis revealed a negligible albeit significant effect size (0.119, p < .05). Risk was found to be higher in bulimia nervosa (BN, delta = 0.462, p = < .001), smaller in binge eating disorder (delta = 0.14, p < .05) and non-significant in anorexia nervosa (AN, delta = -.167, p = .070).
CONCLUSIONS: The differential risk observed in patients with BN might be related to differences in temperament or might be the result of reward sensitization. 2009 John Wiley & Sons, Ltd and Eating Disorders Association

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19475697     DOI: 10.1002/erv.936

Source DB:  PubMed          Journal:  Eur Eat Disord Rev        ISSN: 1072-4133


  20 in total

1.  Pharmacotherapies for Overeating and Obesity.

Authors:  S Yarnell; M Oscar-Berman; Nm Avena; K Blum; Ms Gold
Journal:  J Genet Syndr Gene Ther       Date:  2013-04-01

Review 2.  Dopamine and binge eating behaviors.

Authors:  Nicholas T Bello; Andras Hajnal
Journal:  Pharmacol Biochem Behav       Date:  2010-04-24       Impact factor: 3.533

3.  The FODRAT study (FOod addiction, DRugs, Alcohol and Tobacco): first data on food addiction prevalence among patients with addiction to drugs, tobacco and alcohol.

Authors:  B Tinghino; F Lugoboni; A Amatulli; C Biasin; M Bramani Araldi; D Cantiero; M Cremaschini; G L Galimberti; S Giusti; C Grosina; G E G Mulazzani; U Nizzoli
Journal:  Eat Weight Disord       Date:  2020-02-18       Impact factor: 4.652

Review 4.  Does a shared neurobiology for foods and drugs of abuse contribute to extremes of food ingestion in anorexia and bulimia nervosa?

Authors:  Walter H Kaye; Christina E Wierenga; Ursula F Bailer; Alan N Simmons; Angela Wagner; Amanda Bischoff-Grethe
Journal:  Biol Psychiatry       Date:  2013-02-04       Impact factor: 13.382

Review 5.  Nothing tastes as good as skinny feels: the neurobiology of anorexia nervosa.

Authors:  Walter H Kaye; Christina E Wierenga; Ursula F Bailer; Alan N Simmons; Amanda Bischoff-Grethe
Journal:  Trends Neurosci       Date:  2013-01-18       Impact factor: 13.837

6.  Exploring the relationship between eating disorder symptoms and substance use severity in women with comorbid PTSD and substance use disorders.

Authors:  Therese Killeen; Timothy D Brewerton; Aimee Campbell; Lisa R Cohen; Denise A Hien
Journal:  Am J Drug Alcohol Abuse       Date:  2015-09-14       Impact factor: 3.829

7.  General impulsivity in binge-eating disorder.

Authors:  Rebecca G Boswell; Carlos M Grilo
Journal:  CNS Spectr       Date:  2020-07-21       Impact factor: 3.790

8.  The association between overweight and illegal drug consumption in adolescents: is there an underlying influence of the sociocultural environment?

Authors:  Francesca Denoth; Valeria Siciliano; Patricia Iozzo; Loredana Fortunato; Sabrina Molinaro
Journal:  PLoS One       Date:  2011-11-16       Impact factor: 3.240

9.  How Prevalent is "Food Addiction"?

Authors:  Adrian Meule
Journal:  Front Psychiatry       Date:  2011-11-03       Impact factor: 4.157

10.  Prevalence of alcohol use disorder among individuals who binge eat: a systematic review and meta-analysis.

Authors:  Krzysztof Bogusz; Maciej Kopera; Andrzej Jakubczyk; Elisa M Trucco; Katarzyna Kucharska; Anna Walenda; Marcin Wojnar
Journal:  Addiction       Date:  2020-07-13       Impact factor: 6.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.